arrow_back Back to App

Sickle Cell Disease Awareness Month: Support for Research and Treatment Access

This resolution supports designating September 2022 as Sickle Cell Disease Awareness Month. Its aim is to increase public knowledge about the disease, the need for research, early detection, and better treatment methods, which can improve the quality of life for affected individuals and their families. Citizens will be encouraged to participate in educational events.
Key points
Support for Sickle Cell Disease Awareness Month to educate the public about the condition.
Call for equitable access to innovative therapies, including gene therapies, for all who need them.
Encouragement to organize events raising awareness about sickle cell disease and available care programs.
Plea for the formation of an interagency cabinet to develop policies supporting treatment access and eliminating bias in the healthcare system.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HRES_1330
Sponsor: Rep. Davis, Danny K. [D-IL-7]
Process start date: 2022-09-02
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Expressing support for the designation of September 2022 as "Sickle Cell Disease Awareness Month" in order to educate communities across the United States about sickle cell disease and the need for research, early detection methods, effective treatments, and preventative care programs with respect to complications from sickle cell disease and conditions related to sickle cell disease.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HRES_1330.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-09-02.

What are the main provisions?

Key points include:

  • Support for Sickle Cell Disease Awareness Month to educate the public about the condition.
  • Call for equitable access to innovative therapies, including gene therapies, for all who need them.
  • Encouragement to organize events raising awareness about sickle cell disease and available care programs.
  • Plea for the formation of an interagency cabinet to develop policies supporting treatment access and eliminating bias in the healthcare system.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Davis, Danny K. [D-IL-7].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

CATEGORIES

Health